FK506 binding protein inhibitors (Plex Pharmaceuticals)

N/A

Report date: 2025/06/11 10:30:26
NME

Base Information

Drug NameFK506 binding protein inhibitors (Plex Pharmaceuticals)
Drug Alias NameFK506 binding protein inhibitors (CalAsia Pharmaceuticals)CAP-1551
ClassificationSmall molecules
Mechanisms of ActionFK506 binding protein inhibitors
TargetsFK506 binding protein
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPlex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPlex Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A